Mineralys Therapeutics, Inc. (MLYS)

NASDAQ

$21.39

$-0.07

(-0.32%)

Regular Market

Mineralys Therapeutics, Inc. (MLYS) Live Price Chart

Last updated: ⁦2026-10-21 16:01:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Mineralys Therapeutics, Inc. (MLYS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $21.39, with a market capitalization of $1.85B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $20.12 to $47.65. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.85B
Open	$21.90
Day's High	$47.65
Day's Low	$5.85
Previous Close	$21.58
Volume	191.73K
Average Volume	1.14M
P/E Ratio	--
52-Week High	$47.65
52-Week Low	$20.12
Dividend Yield	--
Earnings Date	--

Mineralys Therapeutics, Inc. (MLYS) Stock Price Today

Mineralys Therapeutics, Inc. (MLYS) is currently trading at $21.39 as of 2026-10-21 15:44:14, down 0.88% ($0.19) from the previous close of $21.58

During today's regular trading session, MLYS has traded between $5.85 and $47.65, with a trading volume of 191.73K shares. The current price is near the middle of today's range.

Mineralys Therapeutics, Inc. (MLYS) 7-Day Stock Price Change

Over the past seven days, Mineralys Therapeutics, Inc. (MLYS) moved from $22.23 to $21.39, representing a decline of 3.78% ($0.84).

The stock traded between $20.12 and $23.10 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.42 million shares, up versus the previous seven-day period, indicating higher trading activity.

MLYS 52-Week Price Position

Position in Range: 4.6%

52W Low$20.12

52W High$47.65

MLYS is currently trading at $21.39, placing it 4.6% of the way from its 52-week low of $20.12 to its 52-week high of $47.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Mineralys Therapeutics, Inc. (MLYS)?

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Mineralys Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	76
Exchange	NASDAQ
Company Website	https://mineralystx.com

How to Buy Mineralys Therapeutics, Inc. (MLYS) Stock on MEXC

Eligible investors can buy real shares of Mineralys Therapeutics, Inc. (MLYS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MLYS and Place Your Order

Open the RealStocks trading page and search for MLYS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Mineralys Therapeutics, Inc. (MLYS) stock price today?

Mineralys Therapeutics, Inc. (MLYS) is currently trading at $ 21.39, down 0.88% ($0.19) from the previous close of $ 21.58. Intraday prices update in real time during regular trading hours.

2.Is MLYS stock going up or down today?

As of 2026-10-21 15:44:14, MLYS is trading at $ 21.39, down 0.88% ($0.19) from its previous close of $ 21.58. The stock has traded between $ 5.85 and $ 47.65 during today’s regular session. Past price movements do not guarantee future results.

3.What is MLYS pre-market price?

As of 2026-10-21 15:44:14, MLYS is trading at $ 21.68 in pre-market trading, up 0.47% ($0.10) from the previous close of $ 21.58. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MLYS after-hours price?

As of 2026-10-21 15:44:14, MLYS is trading at $ 21.48 in after-hours trading, down 0.47% ($0.10) from the regular-session close of $ 21.58. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MLYS stock trading now?

MLYS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MLYS sit relative to its 52-week high and low?

Over the past 52 weeks, MLYS has traded between a low of $ 20.12 and a high of $ 47.65. At $ 21.39, the stock is positioned 4.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Mineralys Therapeutics, Inc. in?

Mineralys Therapeutics, Inc. (MLYS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Mineralys Therapeutics, Inc.'s market capitalization and where is it listed?

Mineralys Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.85B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MLYS valued in terms of P/E ratio and EPS?

MLYS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.95. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Mineralys Therapeutics, Inc. pay a dividend?

Mineralys Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.